Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study.

Melahat Uzel Şener Tuğba Çiçek Ayperi Öztürk

Published in: Sao Paulo medical journal = Revista paulista de medicina (2022)

Persistently high WBC, CRP and neutrophil levels and low lymphocyte levels could be considered to be valuable indicators of mortality among COVID-19 patients treated with tocilizumab. Age and low oxygen saturation are independent risk factors for mortality among patients receiving tocilizumab treatment.

Keyphrases

rheumatoid arthritis
coronavirus disease
juvenile idiopathic arthritis
sars cov
rheumatoid arthritis patients
cardiovascular events
risk factors
disease activity
respiratory syndrome coronavirus
cardiovascular disease
combination therapy